 |
| Ligand ID: ID2 Drugbank ID: DB00249(Idoxuridine) Indication:For use in keratoconjunctivitis and keratitis caused by herpes simplex virus. |
| DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
|---|---|---|---|---|---|---|---|---|---|---|
 Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 2bx3 | MAIN PROTEINASE (SARS-COVSin2774) | 5 / 12 | ILE A 213GLN A 256ALA A 255TYR A 209ARG A 217 | 1.69A | 24.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ILE B 213GLN B 256ALA B 255TYR B 209ARG B 217 | 1.79A | 24.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 2kqv | NSP3 (SARSr-CoV) | 5 / 12 | ILE A 70ILE A 86TYR A 61MET A 102ALA A 109 | 1.70A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 2qiq | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ILE A 213GLN A 256ALA A 255TYR A 209ARG A 217 | 1.80A | 24.09 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | ILE B 358ILE B 379GLN B 380MET B 323GLU B 375 | 1.55A | 20.10 | NoneNoneNoneNone ZN B 901 (-4.0A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 3d0i | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | TRP B 328ILE B 358ILE B 379GLN B 380MET B 323 | 1.58A | 20.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 3scj | ACE2 (Homosapiens) | 5 / 12 | TRP A 328ILE A 358ILE A 379GLN A 380MET A 323 | 1.58A | 19.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 3scj | ACE2 (Homosapiens) | 5 / 12 | TRP B 328ILE B 358ILE B 379GLN B 380MET B 323 | 1.55A | 19.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | ILE B 358ILE B 379GLN B 380MET B 323GLU B 375 | 1.66A | 19.01 | NoneNoneNoneNone ZN B 901 (-3.6A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | HIS A 374ILE A 358ILE A 379MET A 323GLU A 375 | 1.70A | 19.01 | ZN A 901 (-3.5A)NoneNoneNone ZN A 901 (-3.7A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | ILE C 694ILE A 878MET A 882ALA A 885TYR A 886 | 1.37A | 13.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | ILE C 694ILE A 878MET A 882ALA A 885TYR A 886 | 1.32A | 13.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLU C 762ILE C1000ALA C1007ARG C 758GLU C 755 | 1.40A | 15.23 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLU C 762ILE C1000ALA C1007ARG C 758GLU C 755 | 1.42A | 15.23 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLU C 762ILE C1000ALA C1007ARG C 758GLU C 755 | 1.62A | 14.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLU C 762ILE C1000ALA C1007ARG C 758GLU C 755 | 1.59A | 14.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ILE A 694ILE B 878MET B 882ALA B 885TYR B 886 | 1.24A | 14.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ILE A 694ILE B 878MET B 882ALA B 885TYR B 886 | 1.22A | 14.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6iex | MHC CLASS I ANTIGEN (Homosapiens) | 5 / 12 | GLU A 163ILE A 66TYR A 99ARG A 62GLU A 63 | 1.60A | 24.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | ILE C 325GLN C 63ALA C 392ARG C 332GLU C 405 | 1.80A | 20.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6m17 | ACE2 (Homosapiens) | 5 / 12 | ILE D 358ILE D 379GLN D 380MET D 323GLU D 375 | 1.79A | 18.34 | NoneNoneNoneNone ZN D 914 (-4.2A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ILE A 694ILE C 878MET C 882ALA C 885TYR C 886 | 1.42A | 14.59 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ILE A 694ILE C 878MET C 882ALA C 885TYR C 886 | 1.41A | 14.59 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | TRP A 617ILE A 757ILE A 696TYR A 479ALA A 702 | 1.57A | 15.82 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6vw1 | ACE2 (Homosapiens) | 5 / 12 | TRP A 328ILE A 358ILE A 379GLN A 380MET A 323 | 1.62A | 20.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6vw1 | ACE2 (Homosapiens) | 5 / 12 | TRP A 328ILE A 358ILE A 379GLN A 380MET A 323 | 1.64A | 20.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 51ALA H 93ARG H 58GLU H 56 | 1.74A | 20.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 69ALA H 93ARG H 58GLU H 56 | 1.73A | 20.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 51ALA H 97ARG H 59GLU H 57 | 1.67A | 19.71 | NoneNoneNoneNoneMLI E 908 ( 4.4A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 12 | TRP B 47ILE B 51ALA B 97ARG B 59GLU B 57 | 1.74A | 19.71 | NoneNoneNoneNoneMLI B 302 (-4.4A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 12 | TRP B 47ILE B 70ALA B 97ARG B 59GLU B 57 | 1.72A | 19.71 | NoneNoneNoneNoneMLI B 302 (-4.4A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 70ALA H 97ARG H 59GLU H 57 | 1.76A | 19.71 | NoneNoneNoneNoneMLI E 908 ( 4.4A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 70ALA H 97ARG H 59GLU H 57 | 1.65A | 19.71 | NoneNoneNoneNoneMLI E 908 ( 4.4A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 70ALA H 97ARG H 59GLU H 57 | 1.73A | 19.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 51ALA H 97ARG H 59GLU H 57 | 1.71A | 19.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 12 | TRP B 47ILE B 70ALA B 97ARG B 59GLU B 57 | 1.76A | 19.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 12 | TRP B 47ILE B 51ALA B 97ARG B 59GLU B 57 | 1.66A | 19.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 12 | TRP B 47ILE B 70ALA B 97ARG B 59GLU B 57 | 1.65A | 19.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 51ALA H 97ARG H 59GLU H 57 | 1.68A | 19.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 70ALA H 97ARG H 59GLU H 57 | 1.65A | 19.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 12 | TRP B 47ILE B 51ALA B 97ARG B 59GLU B 57 | 1.80A | 19.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 12 | TRP H 47ILE H 70ALA H 97ARG H 59GLU H 57 | 1.76A | 19.71 | None |